STALEY CAPITAL ADVISERS’s Fibrocell Science Inc. FCSC Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,000	Closed	-$18K	–	172
2018 Q1	$18K	Hold	6,000	–	–	﹤0.01%	156
2017 Q4	$19K	Hold	6,000	–	–	﹤0.01%	165
2017 Q3	$92K	Sell	6,000 -567	-9%	-$9.17K	0.01%	163
2017 Q2	$132K	Hold	6,567	–	–	0.01%	162
2017 Q1	$66K	Hold	6,567	–	–	0.01%	142
2016 Q4	$62K	Hold	6,567	–	–	0.01%	134
2016 Q3	$71K	Hold	6,567	–	–	0.01%	130
2016 Q2	$113K	Hold	6,567	–	–	0.01%	132
2016 Q1	$246K	Hold	6,567	–	–	0.03%	112
2015 Q4	$448K	Sell	6,567 -766	-10%	-$55K	0.05%	81
2015 Q3	$423K	Hold	7,333	–	–	0.05%	85
2015 Q2	$580K	Buy	+7,333	New	+$494K	0.06%	77

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STALEY CAPITAL ADVISERS's FCSC Position: Q2 2018 in Review

STALEY CAPITAL ADVISERS sold out of Fibrocell Science Inc. (FCSC) in Q2 2018, closing a stake of 6,000 shares — an estimated $18K sold.

STALEY CAPITAL ADVISERS first reported a position in FCSC in Q2 2015 and held it in 12 quarters. The position peaked at $580K in Q2 2015. 25 funds tracked by Wall St. Rank hold FCSC as of Q2 2018.

STALEY CAPITAL ADVISERS reported no remaining Fibrocell Science Inc. position as of Q2 2018 after selling out during the quarter.
STALEY CAPITAL ADVISERS sold 6,000 Fibrocell Science Inc. shares in Q2 2018, an estimated $18K.
STALEY CAPITAL ADVISERS first reported a position in Fibrocell Science Inc. in Q2 2015 and held it in 12 quarters.
STALEY CAPITAL ADVISERS's Fibrocell Science Inc. position peaked at $580K in Q2 2015.
25 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2018.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q2 2018, filed 8 Aug 2018.